Guoxin Hou
Impact in
- Cancer Research top 10%
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- RNA modifications and cancer
- Epigenetics and DNA Methylation
- Ubiquitin and proteasome pathways
Papers in
-
- RNA modifications and cancer 10
- Cancer therapeutics and mechanisms 4
- Epigenetics and DNA Methylation 3
-
- Cancer-related molecular mechanisms research 4
- MicroRNA in disease regulation 3
- Co-authors
- Shijun Wen (3 shared papers)Panpan Liu (3 shared papers)Jing Yang (1 shared paper)Yumin Hu (3 shared papers)Jing Yang (2 shared papers)Peng Huang (2 shared papers)Jianwei Liao (2 shared papers)Yiming Jiang (4 shared papers)
- Journals
- Cell Death and Disease (2 papers)Cell Death Discovery (1 paper)Journal of Cellular Physiology (1 paper)Carcinogenesis (1 paper)OncoTargets and Therapy (1 paper)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Guoxin Hou
28 papers receiving 572 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 206
- Molecular Biology 387
- Oncology 136
- Pulmonary and Respiratory Medicine 119
- Immunology 71
Countries citing papers authored by Guoxin Hou
This map shows the geographic impact of Guoxin Hou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoxin Hou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoxin Hou more than expected).
Fields of papers citing papers by Guoxin Hou
This network shows the impact of papers produced by Guoxin Hou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoxin Hou. The network helps show where Guoxin Hou may publish in the future.
Co-authors
The 25 scholars most cited alongside Guoxin Hou, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 145 | |
| 2 | 2017 | 83 | |
| 3 | 2018 | 81 | |
| 4 | 2018 | 40 | |
| 5 | 1994 | 24 | |
| 6 | Polyphyllin I (PPI) increased the sensitivity of hepatocellular carcinoma HepG2 cells to chemotherapy. | 2015 | 24 |
| 7 | 2019 | 23 | |
| 8 | 2019 | 21 | |
| 9 | 2022 | 20 | |
| 10 | 2020 | 15 | |
| 11 | 2019 | 14 | |
| 12 | 2021 | 12 | |
| 13 | 2016 | 11 | |
| 14 | 2022 | 8 | |
| 15 | 2023 | 8 | |
| 16 | 2020 | 7 | |
| 17 | 2020 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2022 | 5 |
About Guoxin Hou
Guoxin Hou is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 33 papers that have together received 578 indexed citations. Recurring topics across this work include RNA modifications and cancer (10 papers), Ferroptosis and cancer prognosis (6 papers), Cancer therapeutics and mechanisms (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Mechanisms and Therapy (3 papers), MicroRNA in disease regulation (3 papers), Epigenetics and DNA Methylation (3 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Cancer Research (206 citations), Molecular Biology (387 citations), Oncology (136 citations), Pulmonary and Respiratory Medicine (119 citations) and Immunology (71 citations). Guoxin Hou has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Shijun Wen, Panpan Liu, Jing Yang, Yumin Hu, Jing Yang, Peng Huang, Jianwei Liao, Yiming Jiang, Wenhao Han and Jingjing Deng. Their work appears in journals such as Cell Death and Disease, Cell Death Discovery, Journal of Cellular Physiology, Carcinogenesis and OncoTargets and Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.